Design of a Drug-Eluting Subcutaneous Implant of the Antiretroviral Tenofovir Alafenamide Fumarate

PURPOSE: Sexual transmission of HIV has been clinically proven to be preventable with a once-daily oral tablet; however, missed doses dramatically increase the risk of HIV infection. Long-acting subcutaneous implants do not allow the user to miss a dose. A desirable long-acting drug-eluting implant...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharm Res
Asıl Yazarlar: Simpson, Solange M, Widanapathirana, Lakmini, Su, Jonathan T., Sung, Samuel, Watrous, David, Qiu, Jiang, Pearson, Elizabeth, Evanoff, Alex, Karunakaran, Dipu, Chacon, Jorge E., Kiser, Patrick F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer US 2020
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160069/
https://ncbi.nlm.nih.gov/pubmed/32296951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-020-2777-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller